Search

everythinglearnresearchcommunity

for

Search:↓

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Adding a second method to PROTACs could improve cancer treatment.

Organoids can revolutionize medicine by modeling diseases and aiding in personalized treatments.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

Maxillariinae orchids contain 62 compounds with potential health benefits, including treating skin conditions and diseases like cancer and diabetes.

Some steroid-induced health issues in rodents improved after stopping treatment, but hair loss and eye problems did not.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

An 84-year-old woman's hair loss was due to a rare condition called Leydig cell hyperplasia, which was treated with surgery.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Substance P may worsen acne by increasing inflammation, but corticosteroids might help by reducing this effect.

Hair transplants are effective for male and female pattern baldness, have evolved in technique, and require careful planning for natural results and managing complications.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

Women with PCOS in Missan Province have higher weight, hormonal imbalances, and metabolic issues.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Adequate testosterone is crucial for men's health and quality of life, but its decline with age needs more research.

Lipid peroxides can cause early hair loss by damaging hair follicles.

Hair loss in balding individuals is linked to changes in specific hair growth-related genes.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Melatonin applied to the scalp helps increase hair density in people with early hair loss.

Melatonin applied to the scalp helps treat early-stage hair loss in men and women.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Androgenetic alopecia with telogen effluvium is the most common hair loss in women with hirsutism.